Evidence map›Paper›PMID 22438886›Full record

ArticlePloS one2012

Melt analysis of mismatch amplification mutation assays (Melt-MAMA): a functional study of a cost-effective SNP genotyping assay in bacterial models.

Dawn N Birdsell, Talima Pearson, Erin P Price, Heidie M Hornstra, Roxanne D Nera, Nathan Stone, Jeffrey Gruendike, Emily L Kaufman, Amanda H Pettus, Audriana N Hurbon and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pathogens (Basel, Switzerland) · 2025
    Article
  6. Persistence in time: the hunt forApplied and environmental microbiology · 2025
    Article
  7. Archival and Newly Isolated HistoricalPathogens (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Comparative genomics ofMicrobial genomics · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

Dawn N BirdsellCenter for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, Arizona, United States of America.
Talima Pearson
Erin P Price
Heidie M Hornstra
Roxanne D Nera
Nathan Stone
Jeffrey Gruendike
Emily L Kaufman
Amanda H Pettus
Audriana N Hurbon
Jordan L Buchhagen
N Jane Harms
Gvantsa Chanturia
Miklos Gyuranecz
David M Wagner
Paul S Keim
Northern Arizona University · USHungarian Academy of Sciences · HUIlia State University · GEUniversity of Saskatchewan · CA

Funding

NIAID NIH HHS N01 AI015447
6 · The paper itself

Abstract

Single nucleotide polymorphisms (SNPs) are abundant in genomes of all species and biologically informative markers extensively used across broad scientific disciplines. Newly identified SNP markers are publicly available at an ever-increasing rate due to advancements in sequencing technologies. Efficient, cost-effective SNP genotyping methods to screen sample populations are in great demand in well-equipped laboratories, but also in developing world situations. Dual Probe TaqMan assays are robust but can be cost-prohibitive and require specialized equipment. The Mismatch Amplification Mutation Assay, coupled with melt analysis (Melt-MAMA), is flexible, efficient and cost-effective. However, Melt-MAMA traditionally suffers from high rates of assay design failures and knowledge gaps on assay robustness and sensitivity. In this study, we identified strategies that improved the success of Melt-MAMA. We examined the performance of 185 Melt-MAMAs across eight different pathogens using various optimization parameters. We evaluated the effects of genome size and %GC content on assay development. When used collectively, specific strategies markedly improved the rate of successful assays at the first design attempt from ~50% to ~80%. We observed that Melt-MAMA accurately genotypes across a broad DNA range (~100 ng to ~0.1 pg). Genomic size and %GC content influence the rate of successful assay design in an independent manner. Finally, we demonstrated the versatility of these assays by the creation of a duplex Melt-MAMA real-time PCR (two SNPs) and conversion to a size-based genotyping system, which uses agarose gel electrophoresis. Melt-MAMA is comparable to Dual Probe TaqMan assays in terms of design success rate and accuracy. Although sensitivity is less robust than Dual Probe TaqMan assays, Melt-MAMA is superior in terms of cost-effectiveness, speed of development and versatility. We detail the parameters most important for the successful application of Melt-MAMA, which should prove useful to the wider scientific community.

Indexed as

Bacteriological TechniquesPolymorphism, Single NucleotideAllelesBacteriaBase CompositionBase Pair MismatchBase SequenceCost-Benefit AnalysisDNA, BacterialDNA Mutational AnalysisDNA PrimersGenome, BacterialGenotypeHumansModels, GeneticNucleic Acid Amplification TechniquesDNA, BacterialDNA Primers

Identifiers

PMID22438886
PMCPMC3306377
OpenAlexW1976672951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.